AVer Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Medical-Grade PTZ Cameras
SAN ANTONIO, July 23, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that AVer Information Inc. has received the 2025 Global Company of the Year Recognition in the medical-grade PTZ cameras industry for its outstanding achievements in technology innovation, healthcare-focused strategy execution, and customer impact. This recognition highlights AVer's consistent leadership in driving measurable outcomes, strengthening its market position, and delivering customer-centric innovation in an evolving competitive landscape.
Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. AVer excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with efficiency, consistency, and scale. "AVer is right in the middle of a significant transformation in healthcare delivery, with products and services that enable and positively contribute to this change," said David Frigstad, Chairman at Frost & Sullivan.
Guided by a long-term growth strategy focused on AI-driven innovation, platform-agnostic product design, and healthcare collaboration, AVer has shown its ability to adapt and lead in a rapidly evolving landscape. The company's strategic agility and sustained investment in connected healthcare solutions have enabled it to scale effectively across clinical and homecare environments.
Innovation remains central to AVer's approach. Its suite of medical-grade PTZ cameras addresses the full spectrum of telehealth, tele-ICU, tele-sitting, and remote patient monitoring needs, offering seamless integration, scalability, and high-performance video capabilities. "We are thrilled to receive this prestigious award from Frost & Sullivan, one of the leading research firms in the healthcare industry," said Andy Hsi, CEO, AVer Information Inc. "AVer as a company is committed to making a positive difference in the revolutionary telehealth industry, empower smart healthcare environments and help create better patient outcomes for caregivers with our AI and video innovations."
AVer's unwavering commitment to customer experience further strengthens its position in the market. By offering robust support resources—such as training videos, comprehensive manuals, and localized expert assistance via phone, email, or video conferencing—the company ensures that every implementation is successful. Its platform-agnostic camera designs simplify deployments across diverse healthcare settings, enhancing adoption and long-term value.
Frost & Sullivan commends AVer for setting a high standard in competitive strategy, execution, and market responsiveness. The company's vision, innovation pipeline, and customer-first culture are shaping the future of connected healthcare and driving tangible results at scale.
Each year, Frost & Sullivan presents the Company of the Year Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. It recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence.
Frost & Sullivan Best Practices recognitions honor companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Contact:
E: [email protected]
About AVer Information Inc.
Founded in 2008, AVer is an award-winning provider of education technology, healthcare and video collaboration camera solutions that improve productivity and enrich learning. From accelerating learning in the classroom, safely supporting patient care, to increasing competitive advantage for businesses, AVer solutions leverage the power of technology to help people connect with one another to achieve great things. Our product portfolio includes Professional Grade Artificial Intelligence Enabled Auto Tracking Cameras, Medical Grade PTZ Cameras, Zoom and Microsoft Teams Certified Enterprise Grade USB Cameras, Document Cameras and Classroom Audio Solutions. We strive to provide industry leading service and support that exceeds our customer's expectations. We are also deeply committed to our community, the environment and employ stringent green processes in all we do.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
13 hours ago
- Cision Canada
AVer Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Medical-Grade PTZ Cameras
Recognized for its AI-driven innovation, platform-agnostic product design, and exceptional customer-centric healthcare video solutions SAN ANTONIO, July 23, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that AVer Information Inc. has received the 2025 Global Company of the Year Recognition in the medical-grade PTZ cameras industry for its outstanding achievements in technology innovation, healthcare-focused strategy execution, and customer impact. This recognition highlights AVer's consistent leadership in driving measurable outcomes, strengthening its market position, and delivering customer-centric innovation in an evolving competitive landscape. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. AVer excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with efficiency, consistency, and scale. "AVer is right in the middle of a significant transformation in healthcare delivery, with products and services that enable and positively contribute to this change," said David Frigstad, Chairman at Frost & Sullivan. Guided by a long-term growth strategy focused on AI-driven innovation, platform-agnostic product design, and healthcare collaboration, AVer has shown its ability to adapt and lead in a rapidly evolving landscape. The company's strategic agility and sustained investment in connected healthcare solutions have enabled it to scale effectively across clinical and homecare environments. Innovation remains central to AVer's approach. Its suite of medical-grade PTZ cameras addresses the full spectrum of telehealth, tele-ICU, tele-sitting, and remote patient monitoring needs, offering seamless integration, scalability, and high-performance video capabilities. "We are thrilled to receive this prestigious award from Frost & Sullivan, one of the leading research firms in the healthcare industry," said Andy Hsi, CEO, AVer Information Inc. "AVer as a company is committed to making a positive difference in the revolutionary telehealth industry, empower smart healthcare environments and help create better patient outcomes for caregivers with our AI and video innovations." AVer's unwavering commitment to customer experience further strengthens its position in the market. By offering robust support resources—such as training videos, comprehensive manuals, and localized expert assistance via phone, email, or video conferencing—the company ensures that every implementation is successful. Its platform-agnostic camera designs simplify deployments across diverse healthcare settings, enhancing adoption and long-term value. Frost & Sullivan commends AVer for setting a high standard in competitive strategy, execution, and market responsiveness. The company's vision, innovation pipeline, and customer-first culture are shaping the future of connected healthcare and driving tangible results at scale. Each year, Frost & Sullivan presents the Company of the Year Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. It recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence. Frost & Sullivan Best Practices recognitions honor companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact: E: [email protected] About AVer Information Inc. Founded in 2008, AVer is an award-winning provider of education technology, healthcare and video collaboration camera solutions that improve productivity and enrich learning. From accelerating learning in the classroom, safely supporting patient care, to increasing competitive advantage for businesses, AVer solutions leverage the power of technology to help people connect with one another to achieve great things. Our product portfolio includes Professional Grade Artificial Intelligence Enabled Auto Tracking Cameras, Medical Grade PTZ Cameras, Zoom and Microsoft Teams Certified Enterprise Grade USB Cameras, Document Cameras and Classroom Audio Solutions. We strive to provide industry leading service and support that exceeds our customer's expectations. We are also deeply committed to our community, the environment and employ stringent green processes in all we do.
Cision Canada
2 days ago
- Cision Canada
BostonGene Receives Frost & Sullivan's 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation
BostonGene's comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development risk and advance precision oncology across all stages the R&D continuum SAN ANTONIO , July 22, 2025 /CNW/ -- Frost & Sullivan has named BostonGene the recipient of the 2025 North American Enabling Technology Leadership Award in recognition of the company's pioneering role in advancing precision oncology. BostonGene's clinically validated, AI-powered platform uses a multimodal approach to decode disease and uncover predictive biological signatures. BostonGene combines data from genes, RNA, proteins, the immune system and the tumor environment to help pharma and biotech develop targeted therapies, design efficient trials, and improve outcomes. Its "Comprehensive Digital Patient" model enables precise drug targeting, biomarker validation and patient stratification. With high test success and fast turnaround, BostonGene accelerates data-driven clinical decisions. "BostonGene has developed state-of-the-art AI-driven, next-generation analytics technologies and is the only known source capable of delivering such comprehensive and integrated analyses," said Unmesh Lal , Healthcare Research Director at Frost & Sullivan. "What truly differentiates BostonGene is its ability to turn vast, complex datasets into clinically meaningful insights with speed and accuracy—delivering real impact not just in research settings but in real-world clinical and drug development environments where timely, actionable data is critical." Backed by a decade of scientific investment and a growing intellectual property portfolio, BostonGene's capabilities span internal lab services, advanced analytics and multimodal assay integration. Its CLIA-certified, CAP-accredited and NYS-approved regulatory infrastructure ensures quality and compliance across global partnerships. "By delivering tailored solutions, accelerating project timelines and driving innovation through advanced analytics, BostonGene is fundamentally transforming oncology drug development," said Manuel Albornoz , Best Practices Research Analyst at Frost & Sullivan. "Its adaptability, speed and scientific rigor make it a trusted partner for the industry." "This recognition reinforces our commitment to equipping drug developers with the tools they need to make smarter, faster decisions," said Nathan Fowler , MD, Chief Medical Officer at BostonGene. "By integrating multiomic data and modeling the tumor microenvironment, we help our partners optimize trial design, improve patient selection and accelerate the development of targeted therapies." Each year, Frost & Sullivan presents this award to a company that has developed a breakthrough technology with the potential to significantly enhance existing products and enable the creation of new solutions and applications. The award highlights technologies with strong potential for market adoption and industry impact. Frost & Sullivan Best Practices Awards honor companies across regional and global markets that demonstrate excellence in innovation, leadership, customer service and strategic product development. Recipients are selected through a rigorous evaluation process involving in-depth interviews, market analysis and extensive secondary research to identify companies that set the benchmark for industry best practices. Read the final report here. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion . Contact: Ashley Shreve Marketing Coordinator - Best Practices Recognition [email protected] Phone: +1.210.844.2505 About BostonGene Corporation BostonGene helps drug developers de-risk and accelerate research and development using a clinically validated AI platform purpose-built for oncology and supported by a CLIA-certified and CAP-accredited clinical laboratory. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights that inform trial design, optimize patient selection and improve clinical outcomes. Our diagnostic and treatment recommendation solutions are used in clinical settings to personalize care and guide therapy decisions for patients. For more information, visit .For more information, visit . Contact: Erin Keleher [email protected] Phone: +1-617-283-2285 SOURCE Frost & Sullivan
Cision Canada
2 days ago
- Cision Canada
Baya Systems Receives Frost & Sullivan's 2025 Global Semiconductor IP Interconnect Solutions Technology Innovation Leadership Recognition for Advancing Flexible, Scalable High-Performance Architectures
Recognized for technology leadership in unified interconnect architecture, customer success, and its ability to meet emerging needs across AI and HPC markets SAN ANTONIO, July 22, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that Baya Systems has been recognized with the 2025 Global Technology Innovation Leadership Recognition in the semiconductor IP interconnect solutions industry for its outstanding achievements in product innovation, strategic execution, and customer impact. This recognition highlights Baya Systems' consistent leadership in driving measurable outcomes, strengthening its brand equity, and delivering customer-centric innovation in an evolving global landscape. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Baya Systems excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with efficiency, consistency, and scale. "Baya Systems is quickly becoming a recognized player in the semiconductor IP interconnect solutions industry. The company partners with leaders across various industries, designing solutions fitting their specific and emerging projects. It focuses on solving high-end problems, helping industry leaders successfully expand their technological capabilities to meet emerging needs," said Varun Babu, Industry Principal, GOA, Frost & Sullivan. Guided by a long-term growth strategy focused on empowering flexibility, scalability, and significant performance through technology leadership, Baya Systems has demonstrated its ability to adapt and lead in a highly competitive landscape. Its continued investment in data movement, chiplet interconnects, and AI/HPC optimization has enabled it to scale globally and meet the needs of established players and next-generation innovators. Innovation remains central to Baya Systems' approach. Its unified interconnect fabric features a software-driven, algorithm-based design with modular, scalable IP that adapts across chiplet and SoC architectures. Optimized for AI and HPC environments, the architecture supports multiple protocols and coherency requirements while reducing design risk and cost. "When we founded Baya Systems two years ago our mission was clear: lead the shift towards software-driven, systems-level thinking in semiconductor interconnects. This recognition by Frost & Sullivan's validates our vision and strategy to execute this goal," said Dr. Sailesh Kumar, CEO and founder of Baya Systems. "Our unified fabric is enabling customers to meet the growing demand of AI and HPC, delivering scalable, flexible performance where it matters most. This achievement belongs to the entire Baya team and our innovative partners; with our collective expertise and future-focused approach, I anticipate that this recognition will be only the first of many." Baya Systems' unwavering commitment to customer success further strengthens its competitive position. The company integrates customer feedback into its innovation roadmap, ensuring that each deployment enhances not only the client's outcomes but also future product capabilities. With its royalty-based pricing model tied to customer project success, Baya Systems aligns technology performance with business value—enhancing trust, transparency, and long-term partnerships. Frost & Sullivan commends Baya Systems for setting a high standard in competitive strategy, execution, and market responsiveness. The company's vision, modular technology framework, and customer-first culture are shaping the future of the semiconductor IP interconnect landscape and driving tangible results at scale. Each year, Frost & Sullivan presents the Technology Innovation Leadership Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. This recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence. Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact: E: About Baya Systems Baya Systems is leading the next wave of foundational, high-performance, and modular semiconductor systems technologies that are chiplet-ready and accelerate intelligent compute everywhere. Inspired by the baya bird's nest-weaving ability, Baya integrates best-in-class compute, communication, and I/O components into seamless, energy-efficient solutions. Its software-based design and exploration platform enhances performance, yield and reusability, enabling cutting-edge, cost-effective innovation across multiple industries. Baya is backed by leading investors including Matrix Partners, Maverick Silicon, Synopsys Inc., and Intel Capital. For more information, visit or follow us on LinkedIn.
